Cargando…
Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
BACKGROUND: Recent study showed that individuals with type 2 diabetes have a high risk of developing colorectal cancer (CRC), in which Receptor for Advanced Glycation End Products (RAGE) plays a pivotal role. We conducted a cross-sectional study to examine the relationships of circulating sRAGE, CRC...
Autores principales: | Zhou, Xiaohai, Lin, Ning, Zhang, Mingjie, Wang, Xiaoling, An, Ye, Su, Qing, Du, Peng, Li, Bo, Chen, Hanbei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666469/ https://www.ncbi.nlm.nih.gov/pubmed/33187505 http://dx.doi.org/10.1186/s12902-020-00647-9 |
Ejemplares similares
-
Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients
por: Asgeirsson, Theodor, et al.
Publicado: (2011) -
Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects
por: Kotani, Kazuhiko, et al.
Publicado: (2011) -
Advanced glycation end products promote ChREBP expression and cell proliferation in liver cancer cells by increasing reactive oxygen species
por: Chen, Hanbei, et al.
Publicado: (2017) -
Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014) -
Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
por: Assiri, Adel M. A., et al.
Publicado: (2018)